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Work in the past lOy has greatly expanded our 
knowledge regarding the role of neurotrophins and, 
in particular, nerve growth factor, in skin. During 
fetal development, neurotrophins are expressed both 
in the mesenchyme and the epithelium of developing 
skin, and they play a trophic role supporting the 
survival of innervating neurons. Nerve growth factor 
appears to have an important role also in the adult 
organism. It serves as a regulatory molecule during 
skin inflammation and repair, affecting both the neu­
ronal and the immune systems. Recent studies also 
suggest that nerve growth factor is an important 
autrocrine growth factor and survival factor for ke­
ratinocytes, cells that express both high- and low-
N erve growth factor (NGF) is a nenrotrophic polypeptide required for the survival and differen­tiation of sensory and sympathetic neurons (Levi­Montalcini, 1987). NGF was discovered approxi­mately 40 y ago by Levi-Montalcini (1954) and 
was isolated by Cohen (1960). It was subsequently purified and 
characterized as a protein composed of two identical 118-amino 
acid chains (Angeletti and Bradshaw, 1971). The gene that encodes 
NGF was cloned and sequenced in 1983 (Scott et ai, 1983; Ulrich et 
ai, 1983). Recently, it has been discovered that NGF belongs to a 
small family of structurally and functionally related proteins termed 
neurotrophins (NTs), which include brain-derived neurotrophic 
factor (BDNF) (Barde et ai, 1982), NT -3 (Maisonpierre et ai, 1990), 
and NT-4/5 (Hallbrook et ai, 1991). 
All neurotrophic molecules exert their effect by binding two 
classes of transmembrane receptors: a low-affinity receptor of �75 
kDa (p75) Oohnson et aI, 1986) and a high-affinity, tyrosine kinase 
receptor of �140 kDa that belongs to the trk family of receptors 
(Bothwell, 1991; Kaplan et ai, 1991). All NTs bind the p75 receptor 
with equal low affinities (Chao et ai, 1986; Rodriguez-Tebar et ai, 
1990; Hallbrook et ai, 1991; Squinto et ai, 1991), but its role in 
mediating NT effect is still controversial (Hempstead et ai, 1991). 
The trk receptors appear to be more specific. NGF has a high 
binding specificity for trk A receptor (gp140) (Kaplan et ai, 1991). 
BDNF binds preferentially to trk B receptor (gp145) (Squinto et ai, 
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affinity receptors for nerve growth factor. Neural 
crest-derived melanocytes also express receptors for 
nerve growth factor. Nerve growth factor appears to 
have a major role during skin injury, e.g., preventing 
melanocyte apoptotic cell death following UV irradi­
ation. Thus, epidermal events interact to maintain 
the number and function of both melanocytes and 
keratinocytes in skin. These recent insights into the 
mechanisms underlying nerve growth factor effects 
in skin may eventually result in the development of 
novel therapeutic modalities. Key words: melanocytesl 
neurotrophinslkeratinocytes. Journal of Investigative Derma­
tology Symposium Proceedings 2:31-36, 1997 
1991), whereas trk C receptor (gp145) binds only NT-3 (Lamballe 
et ai, 1991). 
Recent studies using knock-out mice or mice with trk-specific 
mutations have provided crucial evidence for the physiologic 
importance of NTs during the development of the nervous system 
Oohnson and Oppenheim, 1994). Mutations of trk A gene, render­
ing the receptor inactive, result in mice lacking sympathetic 
neurons of the peripheral nervous system, as well as subpopulations 
of sensory neurons. The pathologic phenotype is strikingly similar 
to that observed after treatment with anti-NGF antibodies during 
fetal development (Smeyne et ai, 1994). Trk B knock-out mice 
display a significant decrease in the number of sensory cranial and 
spinal neurons, as well as loss of some cranial and spinal motoneu­
rons (Klein et ai, 1993). Trk C knock-out mice exhibit sensory 
losses, but no reduction in the number of motoneurons (Klein et ai, 
1994). These results suggest that different NTs have a distinct range 
of biologic activities, affecting different populations of developing 
neurons Oohnson and Oppenheim, 1994). In addition, the above 
studies have demonstrated that some neurons are more affected by 
the loss of the receptor than by the loss of its ligand, suggesting that 
more than one neurotrophic factor binds and activates a specific 
receptor Oohnson and Oppenheim. 1994). 
NGF IN SKIN 
Developtnent The skin is richly innervated with sensory and 
sympathetic nerves (Fantini et ai, 1993). In the skin. NGF has been 
shown to play a crucial role in promoting the survival of the 
developing peripheral nervous system. In mice. during cutaneous 
development, NGF is expressed at high levels in both the epidermis 
and the dermis, although the level of NGF mRNA is higher in the 
developing epithelium (Davies et al. 1987). NGF synthesis begins 
with the arrival of the first axons to the epidermis (target-field). and 
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the level of NGF mRNA increases thronghout the period of skin 
innervation between embryonic days 11 and 14 (Davies et ai, 19!17). 
Furthermore, the levels of the low-afl-lnity NGF receptor (NGF-R) 
p75 (Wyatt el ai, 1990) and of the tyrosine kinase NGF-R trk A 
(Wyatt and Davies, unpublished data) increase markedly in neurons 
when their axons reach the cutaneous target fIelds. The low-affinity 
NGF-R mRNA expression in developing skin is restricted to the 
mesenchyme. It is detected as early as embryonic day 9.5, approx­
imately 36 h before the onset of NGF synthesis (Wyatt el ai, 1990). 
Recently, using the transgenic mouse model, it has been shown that 
overexpression of NGF in the epidermis is associated with hyper­
trophy of the peripheral sensory and sympathetic nerves (Albers el 
01,1994). 
BDNF and NT-3 mRNAs are detected in developing skin as 
early as embryonic day 9.5. BDNF expression increases up to 
embryonic day 12 and is decreased by day 16. NT-3 transcripts are 
maximally expressed at day 13 and decline to reach the initial low 
level by day 16. Interestingly, NT -3 mRNA levels are 3 times 
higher than BDNF transcripts in the developing skin. BDNF and 
NT -3 transcripts are equally distributed in the epithelium and the 
mesenchyme (Schecterson and Bothwell, 1992; Buchman and 
Davies, 1993). These findings suggest that between days 9 and 16 
of fetal development, skin cells synthesize NTs that support the 
survival of the developing cutaneous innervation. 
Inflammation There is increasing evidence that NGF may mod­
ulate inflammatory responses in skin. During skin inflammation a 
major role is played by neuropeptide molecules. These include 
substance P, neuropeptide Y, calcitonin gene-related peptide, and 
vasoactive intestinal polypeptide (Tausk el 01,1993). The neuropep­
tides are stored in free cutaneous nerve endings and nerve fibers 
that surround blood vessels, hair follicles, and sweat glands. The 
release of neuropeptides during inflammation induces histamine 
secretion from local mast cells as well as blood vessel dilatation and 
tissue edema. 
During skin inflammation there is increased synthesis of neu­
ropeptides such as substance P and calcitonin gene-related peptide 
in the dorsal root ganglia (Oonnerer el ai, 1992). Interestingly, NGF 
has been reported to upregulate the expression of substance P and 
calcitonin gene-related peptide in neurons (Lindsay and Harmar, 
1989; Donnerer el ai, 1993) and to modulate their synthesis in 
mature sensory neurons (Lindsay and Hannar, 1989). Moreover, 
during cutaneous inflammation, NGF content is markedly increased 
in nerves that supply the inflamed area (Weskamp and Otten, 1987; 
Oonnerer et ai, 1992). Furthermore, if NGF is inactivated by 
anti-NGF antibodies, no increase of neuropeptides is observed, 
snggesting that NGF plays a regulatory role ill VillO in the stimula­
tion of neuropeptide synthesis during inflammatory processes 
(Donnerer pi ai, 1993). 
It has recently been reported that in inflammatory dermatoses, 
such as psoriasis, atopic eczema, and contact dermatitis, as well as 
during the course of experimental cutaneous inflammation, sub­
stance P levels in lesional skin are consistently lower than those in 
normal skin (Ek and Theodorsson, 1990; Giannetti et ai, 1992; 
Pincelli el ai, 1992). At the same time, NGF levels are significantly 
increased in inflamed lesional skin from psoriatic patients compared 
to normal healthy skin (Fantini el ai, 1995). It is therefore possible 
that NGF stimulates substance P synthesis at the central level and, 
at the same time, causes increased substance P release and subse­
quently its enzymatic degradation, which accounts for its reduced 
levels in the skin during inflammation. Taken together, these 
findings strongly suggest that NGF, by regulating neuropeptide 
synthesis and release, could participate in inflammatory processes of 
the skin. 
The effect of NGF on cutaneous inflammatory processes is also 
mediated through its direct influence on inflammatory cells. NGF 
increases the number of mast cells in peripheral tissues including the 
skin (Aloe and Levi-Montalcini, 1977), causes massive degranula­
tion of peritoneal mast cells (Bruni el ai, 1982; Pearce and Thomp­
son, 1986), promotes myeloid progenitor cell growth (Matsuda el 
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ai, 1988), induces proliferation and differentiation of B lymphocytes 
(Otten cl 01, 1989), and enhances histamine release by basophils 
(Bischoff and Dahinden, 1992). Furthermore, NGF induces inter­
leukin 1 expression in PC12 cells (Alheim ct ai, 1991) and 
suppresses leukotriene C4 production by human eosinophils (Taka­
fuji, 1992). These data suggest that NGF, by affecting both the 
nervous and immune systems, has a regulatory role in skin inflam­
n1ation. 
NERVE GROWTH FACTOR AND KERATINOCYTES 
Keratinocytes are reported to synthesize and secrete nunlerous 
cytokines (Kupper, 1994). It was reported by Tron for murine 
keratinocytes (Tron ct ai, 1990) and by Di Marco ft al (1991), Yaar 
cl al (1991), and Pincelli el al (1994) for human keratinocytes that 
they express, synthesize, and release NGF. Moreover, NGF of 
keratinocyte origin has been shown to be biologically active in both 
mice and humans. It was demonstrated that medium conditioned by 
keratinocytes promotes neurite outgrowth of sensory neurons 
obtained from chick embryo dorsal root ganglia (Yaar et ai, 1991). 
Di Marco el al (1991) found this neurotrophic effect to be compa­
rable to that induced by 0.1-10 ng NGF per ml, whereas Pincelli et 
al (1994), using the enzyme-linked immunosorbent assay, reported 
NGF release from normal human keratinocytes to be in picogram 
quantities. Whether these different results reflect a difference in the 
sensitivity of the technique or in the conditions of the culture 
systems remains to be determined. 
NGF synthesis and release from keratinocytes have been shown 
to he modulated by ultraviolet radiation B (UVB). In the mouse 
system, UVB initially downregulates keratinocyte NGF mRNA, 
but after 24 h, it augments NGF expression and synthesis (Tron et 
01, 1990). Phorbol ester, known to induce the expression of 
cytokines, also induces NGF mRNA expression in mouse kerati­
nocytes (Tron et ai, 1990). Conversely, in cultured human kerati­
nocytes, the expression of NGF mRNA is strongly inhibited by the 
addition of hydrocortisone (Di Marco el ai, 1991). UV is known to 
affect membrane phospholipid costituents whose derivatives may 
act as second messengers through the activation of phospholipase 
C, which releases diacylglycerol from the membrane. Diacylglyc­
erol, in turn, activates protein kinase C (Nishizuka, 1986). Like 
diacylglycerol, phorbol esters activate protein kinase C (Bell, 1986; 
Nishizuka, 1984). Thus, in keratinocytes NGF expression is prob­
ably regulated, at least in part, by protein kinase C-mediated signal 
transduction pathways (Tron el ai, 1990). 
Interestingly, exponentially growing keratinocytes, but not ke­
ratinocytes of confluent cultures or fully stratified keratinocytes are 
the pool of epidermal cells that synthesize NGF (Di Marco et ai, 
1991). Consistent with the above Endings, it was reported that 
greater amounts of NGF are secreted by proliferating pre-confluent 
keratinocytes than by more differentiated stratified cells (Pin celli et 
ai, 1994). 
NGF synthesis and release by proliferating keratinocytes could 
play an important role during wound healing (Li et ai, 1980). By 
secreting increasing amounts of NGF (Yaar el ai, 1991), keratino­
cytes may regulate skin re-innervation. Indeed, healing wounds 
display intense sprouting of sensory nerve tibers (Hermans son el ai, 
1986). It is also possible that NGF participates in the re-epithelial­
ization of the wound by upregulating the synthesis of certain 
neuropeptides such as vasoactive intestinal polypeptide, which has 
been reported to stimulate the proliferation of human keratinocytes 
(Haegerstrand el ai, 1989; Pin celli et ai, 1992). 
Normal human keratinocytes express both the low- (p75) and 
the high-affinity NGF-Rs (Di Marco et ai, 1993a). Although there 
is a general agreement regarding the identity of the low-affinity 
(p75) NGF receptor in keratinocytes, the expression of trk, the 
gene encoding the high- affinity receptor for NGF, is still a matter 
of debate. Oi Marco cf al (1993a, 1993b), using the polymerase 
chain reaction and primers derived from the intracytoplasmic, 
tyrosine-kinase domain of trk A, failed to detect trk A mRNA in 
human keratinocytes, but instead have identified a new member of 
the trk family, trk E. In contrast, Pincelli et ai, using two different 
VOL. 2, NO. 1 AUGUST 1997 
125 
... 
Q) 
.0 100 E 
:::l 
Z 
Qj 75 
0 
c 
Q) 50 II) 
C'CI 
� 
(,,) 
25 c 
:::e 0 ... 
0 
0 1 2 3 4 
Concentration (ng/ml) 
Figure 1. NGF and EGF increase keratinocyte proliferation. Kera­
tinocytes were cultivated in serum-free medium (KGM) containing increas­
ing concentrations of NGF (_) and EGF (e). Data are expressed as mean :+: 
SEM of triplicate cultures from four independent experiments. Student's t 
test was used for comparisons of the means. (NGF, p < 0.05; EGF, p < 
0.01) 
sets of priIners, one derived from the extracytoplasmic domain of 
trk A (Pincell et ai, 1994) and the other from the 3' untranslated 
region of trk A mRNA (unpublished data), have demonstrated the 
presence of trk A mRNA in human keratinocytes. Further exper­
iments are required to clarifY tllls apparent controversy. 
Addition of NGF to keratinocytes stimulates their proliferation 
(Fig 1) (Pincelli et ai, 1994). At doses of 10 ng per ml, NGF exerts 
mitogenic effects on cultured keratinocytes that are comparable to 
those of epidermal growth factor (EGF) at the same concentrations 
(personal observation). Both NGF and EGF act via transmembrane 
receptors that possess intracellular tyrosine-kinase domains. These 
domains, by phosphorylating tyrosine residues on the intracytoplas­
mic part of the receptor, participate in the progression of the 
mitogenic signal in the cell (Ulrich and Schlessinger, 1990). Like 
EGF receptor, both the low- and high-affinity NGF-Rs are local­
ized to the basal (proliferative) layer of normal human epidermis, 
consistent with their role as receptors for keratinocyte growth 
factors (Nanney et ai, 1984; Fantini and Johansson, 1992; Pincelli et 
al,1994). 
The role of trk in mediating NGF signal in human keratinocytes 
has been confirmed in experiments using the natural alkaloid 
K252a, willch selectively inlllbits the activity of the tyrosine-kinase 
domain of the trk fanllly of receptors (Berg et ai, 1992). Addition of 
K252a to cultured keratinocytes abrogates NGF-induced keratino­
cyte proliferation (Di Marco et ai, 1993b; Pincelli et ai, 1994). In 
addition, Pin celli et al 1 recently showed that autocrine NGF may 
act as a survival factor for mitogen-depleted keratinocytes. Thus, 
NGF appears to act both as a mitogen and as a survival factor for 
human keratinocytes. Recently, it was suggested that NGF, by 
activating distinct signal transduction pathways within the same 
cell, can act either as a nlitogen or as a survival factor for cells that 
express the high-affinity trk receptor. The activation of secondary 
messengers appear to depend on the duration and extent of trk 
phosphorylation (Yaar et ai, 1996). This hypothesis may explain the 
different effects that NGF has on keratinocytes. 
Regarding the role of the low-affmity (p75) NGF-R, studies have 
suggested that it is required for the generation of high-affinity 
1 Pincelli C, Magnoni C. Grassilli E, Benassi L, Ottani D, Franceschi C, 
Giannetti A: Autocrine nerve growth t:Ktor protects human keratinocytes 
from apoptosis through its high-affinity receptor (TRK): A role for BCL-2. 
J /l1l'fSt Dermatol 106:829,1996 (abstr). 
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binding of NGF (Hempstead et ai, 1991). First, in human keratino­
cytes, p75 NGF-receptor mRNA and protein are increased during 
their exponential growth phase (Di Marco et ai, 1993a). Second, 
mice carrying a mutation of the gene encoding for the p75 
NGF-receptor, which renders the protein product inactive, develop 
skin ulcers and hair loss (Lee et ai, 1992). These studies suggest a 
role for both p75 NGF-receptor and trk during kcratinocyte 
proliferation and/or survival. 
NERVE GROWTH FACTOR AND MELANOCYTES 
Melanocytes are neural crest-derived cells that originate from 
melanoblasts (Boissy, 1988; Holbrook et ai, 1989). Melanoblasts 
nligrate from the neural crest as early as 2.5 wk of gestation, and 
during their nligration they differentiate into melanocytes, which 
populate the basal layer of the epidermis and the hair follicles 
(Holbrook et ai, 1989). 
Melanocytes express trk A mRNA, as well as trk A protein of 
130-140 kDa apparent molecular mass, and an additional protein of 
approximately �110 kDa, consistent with a partially glycosylated 
trk A precursor (Yaar et ai, 1994). Melanocytes also express p 75 
NGF receptor mRNA and protein (Peacocke ef ai, 1988). 
NGF was reported to be chemoattractant for neurons (Levi­
Montalcini, 1976; Gundersen and Barrett, 1979) and to promote 
their neurite outgrowth (Millaruelo et ai, 1988; Rogers and Hendry, 
1990; Mohiuddin et ai, 1995). When NGF was fixed to the center 
of a fibronectin coated-culture dish in which melanocytes were 
subsequently plated away from the NGF area, within 5 d melano-
.�----�--Melanocyte5 
Fibronectin--+-----
A 
B c 
Figure 2. Stimulation of melanocyte migration in an NGF gradi­
ent. (AJ Tissue culture dishes were coated with fibronectin, a component of 
the skin basement membrane. Then, NGF or an irrelevant protein (negative 
control) were fixed to the center of the fibronectin-coated dishes. Subse­
quently, melanocytes were plated and left to attach in the periphery of the 
dish, away from the NGF spot. Finally, the petri dishes were filled with 
medium and the cultures were maintained in 37°C. (B) In a dish containing 
an irrelevant protein, proliferation and radially symmetric migration of 
melanocytes from their attachment site are apparent. (C) In a dish contain­
ing NGF, the melanocyte colony is teardrop in shape with preferential 
migration (-» toward the NGF source. There is also local proliferation of 
melanocytes at the center of the dish where NGF was applied. (Dark 
staining at the edge of the dish represents concentrated background staining 
with RJlOdanile blue.) [Reproduced with permission from Yaar cf aI, 1991.] 
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Figure 3. UV irradiation induces apoptosis of melanocytic cells. 
Cells were UV or sham irradiated. Within 24 h after irradiation, DNA 
tragmentation was observed in UV-irradiated (UV) but not sham-irradiated 
(SHM) cells. [Reproduced with permission from Zhai et ai, 1996.] 
cytes migrated and proliferated preferentially toward the NGF spot 
(Fig 2). In addition, whereas melanocytes in the center of the 
colony, away from the NGF spot, lacked dendrites, melanocytes in 
the vicinity of NGF became dendritic. Thus, NGF bound to 
fibronectin appears to be chemotactic for melanocytes and to 
stimulate their dendricity. These data suggest that NGF may play a 
role in melanocyte migration on fibronectin during wound healing. 
Probably the best documented role of NGF in the central and 
peripheral nervous systems is its role as a survival factor, protecting 
neurons from programmed cell death (apoptosis) (Oppenheim et ai, 
1990; Deckwerth and Johnson, 1993). During embryonic develop­
ment, increased NGF availability reduces apoptosis of sympathetic 
and sensory neurons ;11 !JilJo, whereas NGF deprivation leads to 
increased neuronal death (Levi-Montalcini, 1987; Deckwerth and 
Johnson, 1993; Crowley et ai, 1994). In addition, in the adult 
organism NGF can augment the survival of aged neurons (Ruit et 
ai, 1990; Manfridi et ai, 1992; Jiang and Smith, 1993), and it 
contributes to the survival of neurons after injuries such as hypo­
glycemia (Cheng and Mattson, 1991; Cheng and Mattson, 1992), 
axotomy (Tuszynski et ai, 1990; Kawaja et ai, 1992; Henderson et ai, 
NGF 
A B (50 ng/ml) 
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1993), or exposure to neurotoxic substances (Shimohama et ai, 
1993). 
When melanocytic cells are irradiated ill Fitro with doses of UV13 
known to reach the basal layer of the epidermis, they display the 
characteristic DNA fragmentation (ladder) indicating their pro­
grammed cell death (Fig 3). Thus, UV irradiation of melanocytes 
leads to their apoptotic death. 
I nterestingly, il1 lJivo UV irradiation causes apoptotic death 
primarily of keratinocytes whereas melanocyte apoptosis rarely 
occurs (Olson et ai, 1974; Stierner et ai, 1989; Norris et ai, 1993).1 
Furthermore, after UV irradiation, NGF synthesis in epidermal cells 
is upregulated (Tron et ai, 1990), and the level of p75 NGF receptor 
in melanocytes is induced (Yaar et ai, 1991). These data suggest a 
role for NGF in melanocytes during UV irradiation. 
To investigate whether NGF can prevent UV-induced melano­
cyte apoptosis, UV-irradiated melanocytic cells were supplemented 
with NGF or diluent alone as control. The characteristic DNA 
ladder was apparent in UV-irradiated diluent-treated melanocytes 
but was hardly detectable in UV -irradiated NGF-supplemented 
melanocytes (Fig 4A). Furthermore, while the m<tiority of UV­
irradiated diluent-supplemented cells were dying and detaching 
from the dish surface, NGF-supplemented melanocytes appeared 
healthy (Fig 4B). Cell yields of melanocytes irradiated with increas­
ing UV doses and supplemented with NGF were higher than those 
cells supplemented with diluent alone (Fig 4C). These data estab­
lish that NGF can protect melanocytes from UV-induced apoptosis 
and suggest a major paracrine role for NGF in melanocyte survival 
in skin (Zhai et ai, 1996). 
Cells of neural crest origin have been reported to be protected 
from apoptosis by the protein product of the BCL-2 gene, which is 
known to act as a repressor of programmed cell death (Garcia et ai, 
1992; Sato et ai, 1994). To investigate the effect of NGF on BCL-2 
levels, melanocytic cells were UV or sham irradiated and then 
supplemented with NGF or diluent alone. Western blot analysis 
showed low 13CL-2 levels in UV -irradiated diluent-supplemented 
cells or in sham-irradiated cells (Fig 5). BCL-2 level was substan­
tially increased, however, in cells subjected to UV irradiation 
followed by NGF supplementation, suggesting that NGF protects 
2 Zhai S, Pincelli C, Yaar M, GonsalvesJ, Gilchrest BA: The role of nerve 
growth factor in preventing keratinocyte apoptosis. J I1",est Derlllalol 104: 
572, 1995 (abstr). 
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Figure 4. NGF rescues melanocytes from UV-induced apoptosis. Melanocytic cells were UV irradiated and immediately supplemented with 50 
ng/ml NGF or diluent alone. (A) Within 24 h DNA fragmentation was observed in cclls supplemented with diluent alone (-) whereas DNA of cells 
supplemented with NGF (+) was not Ii-agmcntcd. (B) Twcnty lour hours after irradiation, the majority of diluent-supplemented melanocytes were rounded 
and detaching from the dish surface. In contrast, most of the melanocytes in UV -irradiated NGF-supplemented cultures appeared healthy. (C:y Melanocytes 
were irradiated once a day lor 3 d with UV doses ofO, 5, 10, and 25 mJ/cm2. After each UV exposure, cells were maintained in medium containing 50 ng/ml 
NGF or diluent alone. Cell yields ofUV -irradiated NGF-supplemented cultures werc 62':;',-65':;', higher than cell yields of diluent-supplemented cultures. Cell 
yields of sham-irradiated NCF-supplemented melanocytes were 24% higher than cell yields of sham-irradiated diluent-supplemented cultures, suggesting that 
NGF may enhance survival of growth factor-dcprived melanocytes. One representative experiment is shown. [Reproduced with permission from Zhai el ai, 
1 ')')6.1 
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Figure 5. NGF upregulates BCL-2 expression in Illelanocytic cells. 
Sham- or UV-irradiated melanocytic cells were provided NGF or diluent 
alone. Twenty four hours after UV irradiation, NGF-supplcmentcd cells 
expressed higher levels of BCL-2 as compared to sham-irradiated or UV­
irradiated diluent-supplemented cells. [Reproduced with permission from 
Zhai ff at. 1996.] 
mclanocytes from UV -induccd apoptosis by uprcgulating BCL-2 
levels in the cells (Zhai et ai, 1996). Thcsc data suggest that NGF is 
a paracrinc survival factor for melanocytes ill vivo. 
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